These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
152 related articles for article (PubMed ID: 1882086)
21. Long-term treatment with neutral endopeptidase inhibitor improves cardiac function and reduces natriuretic peptides in rats with chronic heart failure. Maki T; Nasa Y; Yamaguchi F; Yoshida H; Mori M; Takada T; Horikawa E; Okano K; Takeo S Cardiovasc Res; 2001 Aug; 51(3):608-17. PubMed ID: 11476752 [TBL] [Abstract][Full Text] [Related]
22. Differential response of neutral endopeptidase 24.11 ("enkephalinase"), and cholinergic and opioidergic markers to hypoglossal axotomy. Back SA; Gorenstein C J Comp Neurol; 1994 Feb; 340(2):149-60. PubMed ID: 8201016 [TBL] [Abstract][Full Text] [Related]
23. Characterization of neutral endopeptidase 24.11 in dog glomeruli. Landry C; Santagata P; Bawab W; Fournié-Zaluski MC; Roques BP; Vinay P; Crine P Biochem J; 1993 May; 291 ( Pt 3)(Pt 3):773-9. PubMed ID: 8489505 [TBL] [Abstract][Full Text] [Related]
24. Increase of neutral endopeptidase-24.11 with cellular density and enzyme modulation with an inhibitor on human Reh6 cell line. Milhiet PE; Beaumont A; Garbay-Jaureguiberry C; Roques BP Biochem Pharmacol; 1992 Apr; 43(8):1711-5. PubMed ID: 1533518 [TBL] [Abstract][Full Text] [Related]
25. Sialorphin, a natural inhibitor of rat membrane-bound neutral endopeptidase that displays analgesic activity. Rougeot C; Messaoudi M; Hermitte V; Rigault AG; Blisnick T; Dugave C; Desor D; Rougeon F Proc Natl Acad Sci U S A; 2003 Jul; 100(14):8549-54. PubMed ID: 12835417 [TBL] [Abstract][Full Text] [Related]
26. [Identification and characterization of neutral endopeptidase in endothelial cells of arterial or venous origin]. Llorens-Cortes C; Huang H; Gasc JM; Corvol P C R Seances Soc Biol Fil; 1992; 186(6):599-611. PubMed ID: 1339590 [TBL] [Abstract][Full Text] [Related]
27. Inhibition of neutral endopeptidase, the degradative enzyme for natriuretic peptides, in rat kidney after oral SCH 42495. Burrell LM; Farina N; Risvanis J; Woollard D; Casely D; Johnston CI Clin Sci (Lond); 1997 Jul; 93(1):43-50. PubMed ID: 9279202 [TBL] [Abstract][Full Text] [Related]
28. Increased expression of renal neutral endopeptidase in severe heart failure. Knecht M; Pagel I; Langenickel T; Philipp S; Scheuermann-Freestone M; Willnow T; Bruemmer D; Graf K; Dietz R; Willenbrock R Life Sci; 2002 Oct; 71(23):2701-12. PubMed ID: 12383878 [TBL] [Abstract][Full Text] [Related]
30. [New approach in the research of analgesics and antihypertensive agents]. Roques BP Ann Pharm Fr; 1991; 49(6):317-26. PubMed ID: 1842170 [TBL] [Abstract][Full Text] [Related]
31. Identification and characterization of neutral endopeptidase in endothelial cells from venous or arterial origins. Llorens-Cortes C; Huang H; Vicart P; Gasc JM; Paulin D; Corvol P J Biol Chem; 1992 Jul; 267(20):14012-8. PubMed ID: 1629199 [TBL] [Abstract][Full Text] [Related]
32. Rat vascular tissue contains a neutral endopeptidase capable of degrading atrial natriuretic peptide. Tamburini PP; Koehn JA; Gilligan JP; Charles D; Palmesino RA; Sharif R; McMartin C; Erion MD; Miller MJ J Pharmacol Exp Ther; 1989 Dec; 251(3):956-61. PubMed ID: 2532252 [TBL] [Abstract][Full Text] [Related]
33. Combined inhibition of neutral endopeptidase with angiotensin converting enzyme or endothelin converting enzyme in experimental diabetes. Tikkanen I; Tikkanen T; Cao Z; Allen TJ; Davis BJ; Lassila M; Casley D; Johnston CI; Burrell LM; Cooper ME J Hypertens; 2002 Apr; 20(4):707-14. PubMed ID: 11910307 [TBL] [Abstract][Full Text] [Related]
34. Role of neutral endopeptidase 24.11 in AV fistular rat model of heart failure. Wegner M; Hirth-Dietrich C; Stasch JP Cardiovasc Res; 1996 Jun; 31(6):891-8. PubMed ID: 8759244 [TBL] [Abstract][Full Text] [Related]
35. Polarized distribution of neutral endopeptidase 24.11 at the cell surface of cultured human intestinal epithelial Caco-2 cells. Jalal F; Jumarie C; Bawab W; Corbeil D; Malo C; Berteloot A; Crine P Biochem J; 1992 Dec; 288 ( Pt 3)(Pt 3):945-51. PubMed ID: 1361726 [TBL] [Abstract][Full Text] [Related]
36. Reversal of cardiac hypertrophy and fibrosis by S21402, a dual inhibitor of neutral endopeptidase and angiotensin converting enzyme in SHRs. Farina NK; Johnston CI; Burrell LM J Hypertens; 2000 Jun; 18(6):749-55. PubMed ID: 10872560 [TBL] [Abstract][Full Text] [Related]
37. Enkephalin-degrading enzymes and angiotensin-converting enzyme in human and rat meninges. Zajac JM; Charnay Y; Soleilhic JM; Sales N; Roques BP FEBS Lett; 1987 May; 216(1):118-22. PubMed ID: 3034668 [TBL] [Abstract][Full Text] [Related]
38. [Membrane metalloendopeptidase (CD10/CALLA): distribution, physiologic and pathophysiologic functions and its inhibitors]. Stanović S; Boranić M Lijec Vjesn; 1998 May; 120(5):131-7. PubMed ID: 9748792 [TBL] [Abstract][Full Text] [Related]
39. Human nasal mucosal neutral endopeptidase (NEP): location, quantitation, and secretion. Ohkubo K; Baraniuk JN; Hohman RJ; Kaulbach HC; Hausfeld JN; Merida M; Kaliner MA Am J Respir Cell Mol Biol; 1993 Nov; 9(5):557-67. PubMed ID: 8217197 [TBL] [Abstract][Full Text] [Related]
40. Increased expression of neprilysin (neutral endopeptidase 24.11) in rat and human hepatocellular carcinomas. Dragović T; Deddish PA; Tan F; Weber G; Erdös EG Lab Invest; 1994 Jan; 70(1):107-13. PubMed ID: 8302012 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]